15:59 Dec 05

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
899.80
-1.95 (-0.22%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Pharmaceuticals Ltd. Financials

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
899.80
-1.95 (-0.22%)
15:59 Dec 05
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

30/100
Technically Bearish

Strength

5

Weakness

4

Opportunity

1

Threats

1

11.23 %

ROE %

7.50 %

ROA %

32.27

EPS

264.10

BVPS

8.74 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
5305.79 5652.62 6228.62 6672.08 6821.08
Operating Expenses +
4431.63 4944.24 5295.27 5663.84 5768.31
Raw Material
1489.61 1630.17 1857.92 2083.13 2122.14
Increase Decrease in Cost
-43.19 78.65 -142.84 -289.77 -315.46
Other Manufacturing Expense
0 50.9 0 0 0
Employee Cost
1133 1169.13 1446.29 1562.34 1605.35
Miscellaneous Expenses
2573.21 2775.57 3043.72 3130.06 2356.28
Operating Profit
874.16 708.38 933.35 1008.24 1052.77
Other Income
50.46 2.74 28.31 42.55 46.93
Depreciation
286.78 275.43 272.67 278.58 283.31
Interest
17.73 50.17 56.19 78.77 89.11
Profit before tax and exceptio..
620.11 385.52 632.8 693.44 727.28
Exceptional Items
0 0 0 12.87 12.87
PBT
620.11 385.52 632.8 706.31 714.41
Provision for Taxation
104.46 12.61 16 125.17 139.16
Net Profit
515.65 372.91 616.8 581.14 600.99
NET Profit after MI
520.94 341.99 615.82 583.42 603.09
EPS
26.5 17.4 31.33 29.68 30.63
Operating Profit Margin (%)
16.48 12.53 14.98 15.11 15.43
Net Profit Margin (%)
9.82 6.05 9.89 8.74 8.84

Alembic Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 69.70 69.70 69.70 69.60 69.60 69.60
FII 4.00 4.00 3.90 4.20 3.90 4.30
Public 16.30 16.40 16.50 16.00 16.10 15.50
Others 10.00 9.90 9.90 10.20 10.40 10.60
Shareholder Shares Holding %
Download Our App On: